Predictors of lung cancer patients delay time in Serbia - a cross-sectional study Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014
Lung cancer in women: What are particularities? Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014
Lung cancer, has it changed in the last ten years? Source: International Congress 2015 – Quality management in lung cancer Year: 2015
Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015
Survival in lung cancer: Associated factors in Tunisian patients Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015
Chemotherapy beyond 3rd line in NSCLC – A retrospective analysis Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015
Lung cancer in England: Trends in survival over the duration of the national lung cancer audit Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013
Is there equitable access to PET-CT for lung cancer patients across a large UK cancer network; a retrospective study of 4597 patients Source: International Congress 2015 – Quality management in lung cancer Year: 2015
Analysis of clinicopathological characteristics of 982 lung cancer patients and subsequent treatment – Epidemiology study Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013
ALK/EML4 translocation in non-squamous NSCLC and their predictors Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
LATE-BREAKING ABSTRACT: Clinical epidemiology of lung cancer in China: a retrospective study of 4205 patients Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014
Gefitinib in front line treatment of patients with NSCLC in the Czech Republic: Analysis of 113 patients Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014
Evaluation of incidental lung cancer in hospitalized patients with non-respiratory disease Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016
Efficacy of preoperative comprehensive pulmonary rehabilitation in patients with lung cancer Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases Year: 2016
Characteristics of smoking behaviour in patients post-curative resection of stage 1 lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015
Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013
Checkpointinhibition in lung cancer – How to distinguish pseudoprogression from progressive disease Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016
Erlotinib (E) in elderly pts with NSCL: Experience at a tertiary referral center Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013
Epidemiological changes of patients with lung cancer over Years Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013
Major changes in men with non-small-cell lung cancer (NSCLC) in 10 years: The KBP-2000-CPHG and KBP-2010-CPHG cohorts Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013